logo-loader
viewArgentex

Argentex trading update shows growth in client numbers and trading volumes boosting sales

Argentex has made a strong start, following its Aim listing in the middle of June

Argentex -
Argentex provides foreign exchange services

Argentex Group PLC (LON:AGFX), the recently listed provider of foreign exchange services to institutions, corporates and high net worth private individuals, generated revenues of £9.3mln in just over three months since its AIM flotation.

Underlying revenues for Argentex LLP, the group's FCA-regulated trading subsidiary, for the full six-month period to 30 September 2019 were £13.8mln, an increase of 45% compared to Argentex LLP's first half numbers.  

The performance was driven by growth in both client numbers and currency volume traded. The company's IPO has furthered its ability to support increasing trading volumes going forward.  

"We are pleased with the company's performance during the period, which reinforces our confidence in meeting expectations for the current financial year and in the group's long-term prospects," said Lord Digby Jones, non-executive chairman of Argentex.

Quick facts: Argentex

Price: 193 GBX

AIM:AGFX
Market: AIM
Market Cap: £218.49 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Argentex named herein, including the promotion by the Company of Argentex in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: SkinBio signs commercial deal with chemical giant Croda

Headlines from the Proactive UK newsroom. SkinBioTherapeutics (LON:SBTX) has signed a commercial and manufacturing agreement for its Skinbiotix technology with speciality chemical giant Croda.  It is the first major deal for the product with Croda to design and manufacture a new active...

on 20/11/19

2 min read